Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on FY 2022 Hospital Inpatient Prospective Payment System Proposed Rule

Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on FY 2022 Hospital Inpatient Prospective Payment System Proposed Rule

HFMA submitted comments to CMS regarding the proposed policy and rate changes for FY 2022 Hospital IPPS for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System. The letter includes comments on the specific proposals related to:   

  • Repeal of the Market-Based MS-DRG Relative Weight Policy
  • Wage Index 
  • Organ Acquisition Costs and Reimbursement
  • Codifying Existing Regulations Related to Organ Acquisition Reimbursement
  • Require Donor Community Hospitals to Charge OPOs Reasonable Costs
  • Solicitation of Comments Regarding Surgeon Fees for Cadaveric Kidney Donor Excisions
  • Close Gaps in Health Equity in Graduate Medical Education (GME)

Download the comment letter

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Payment Reimbursement and Managed Care

Fact Sheet | Payment Reimbursement and Managed Care

CY 2022 Physician Fee Schedule Final Rule Summary - Part I

HFMA presents a detailed summary of the final rule relating to the Medicare physician fee schedule for CY 2022 and other revisions to Medicare Part B policies.

Column | Cost Effectiveness of Health

Accelerated drug approvals present a mounting challenge to oncologists and raises concerns about cost effectiveness for health system finance leaders

In the past year, Americans have witnessed two extremes of the FDA’s accelerated approval process, exposing both profound strengths and worrisome weaknesses. Finance leaders should keep informed about new drug treatment options, their associated costs and efficacy and whether lower-cost alternatives that have the same efficacy are available so they can engage in meaningful conversations with clinicians about which options truly promote cost effectiveness of health.

Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Requirements Related to Surprise Billing, Part II Interim Final Rule

HFMA presents its comment letter to CMS on the Interim Final Rule with comment period implementing certain provisions of the No Surprises Act; Part II issued by the Department of Health and Human Services, the Department of the Treasury, the Department of Labor, and the Office of Personnel, published in the October 7, 2021, Federal Register.

Column | Healthcare Reform

Gail Wilensky: Physician payment and SDoH challenges loom large on nation’s path to value

Two primary obstacles stand in the way of the nation's ability to achieve cost-effective health and healthcare delivery: the slow transition to value-based payment by physicians and the need to address social determinants of health.